The emerging therapy of the medication represents a major development in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide964142.bcbloggers.com/40761289/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment